Lumosa Therapeutics Co (ROCO:6535) Cyclically Adjusted Book per Share: NT$10.86 (As of Dec. 2025)


ROCO:6535 Lumosa Therapeutics Co Ltd ROCO:6535
70 GF Score
Price NT$100.50
GF Value NT$131.16
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Lumosa Therapeutics Co Cyclically Adjusted Book per Share?

Lumosa Therapeutics Co ROCO:6535 70 Cyclically Adjusted Book per Share is NT$10.86 as of Dec. 2025. GuruFocus rates ROCO:6535 with a GF Score™ of 70/100 and a GF Value™ of NT$131.16 (Modestly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lumosa Therapeutics Co's adjusted book value per share for the three months ended in Dec. 2025 was NT$8.960. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$10.86 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Lumosa Therapeutics Co's average Cyclically Adjusted Book Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-11), Lumosa Therapeutics Co's current stock price is NT$100.50. Lumosa Therapeutics Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$10.86. Lumosa Therapeutics Co's Cyclically Adjusted PB Ratio of today is 9.25.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lumosa Therapeutics Co was 35.92. The lowest was 8.93. And the median was 17.59.


Lumosa Therapeutics Co  (ROCO:6535) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lumosa Therapeutics Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=100.50/10.86
=9.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lumosa Therapeutics Co was 35.92. The lowest was 8.93. And the median was 17.59.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lumosa Therapeutics Co Cyclically Adjusted Book per Share Related Terms


Lumosa Therapeutics Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Lumosa Therapeutics Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumosa Therapeutics Co Cyclically Adjusted Book per Share Chart

Lumosa Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 10.64 10.86

Lumosa Therapeutics Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.64 10.78 10.84 10.88 10.86

ROCO:6535 vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Lumosa Therapeutics Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumosa Therapeutics Co Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lumosa Therapeutics Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lumosa Therapeutics Co's Cyclically Adjusted PB Ratio falls into.


ROCO:6535
70GF Score
Lumosa Therapeutics Co Ltd ROCO:6535
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumosa Therapeutics Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lumosa Therapeutics Co's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=8.96/324.0540*324.0540
=8.960

Current CPI (Dec. 2025) = 324.0540.

Lumosa Therapeutics Co Quarterly Data

Book Value per Share CPI Adj_Book
201603 5.859 238.132 7.973
201606 5.321 241.018 7.154
201609 9.840 241.428 13.208
201612 9.199 241.432 12.347
201703 8.694 243.801 11.556
201706 8.137 244.955 10.765
201709 7.651 246.819 10.045
201712 7.205 246.524 9.471
201803 7.360 249.554 9.557
201806 7.057 251.989 9.075
201809 6.943 252.439 8.913
201812 10.857 251.233 14.004
201903 10.192 254.202 12.993
201906 10.311 256.143 13.045
201909 9.648 256.759 12.177
201912 8.840 256.974 11.148
202003 7.900 258.115 9.918
202006 7.239 257.797 9.100
202009 6.845 260.280 8.522
202012 10.671 260.474 13.276
202103 11.532 264.877 14.108
202106 10.793 271.696 12.873
202109 13.814 274.310 16.319
202112 12.957 278.802 15.060
202203 11.840 287.504 13.345
202206 10.657 296.311 11.655
202209 9.719 296.808 10.611
202212 9.970 296.797 10.886
202303 10.868 301.836 11.668
202306 9.952 305.109 10.570
202309 9.226 307.789 9.714
202312 8.471 306.746 8.949
202403 7.822 312.332 8.116
202406 8.276 314.175 8.536
202409 6.834 315.301 7.024
202412 11.319 315.605 11.622
202503 10.739 319.799 10.882
202506 9.596 322.561 9.640
202509 9.447 324.800 9.425
202512 8.960 324.054 8.960

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$10.86 mean?
Lumosa Therapeutics Co (ROCO:6535) has a Cyclically Adjusted Book per Share of NT$10.86 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lumosa Therapeutics Co and its competitors.
Is Lumosa Therapeutics Co's Cyclically Adjusted Book per Share too high?
Lumosa Therapeutics Co's current Cyclically Adjusted Book per Share is NT$10.86. Overall, Lumosa Therapeutics Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lumosa Therapeutics Co's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Lumosa Therapeutics Co's Cyclically Adjusted Book per Share of NT$10.86 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lumosa Therapeutics Co and its competitors. Lumosa Therapeutics Co's current Cyclically Adjusted Book per Share is NT$10.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumosa Therapeutics Co stock overvalued right now?
Based on GuruFocus' analysis, Lumosa Therapeutics Co (ROCO:6535) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$131.16, compared to a current price of NT$100.50 — trading 23.4% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$10.86. Lumosa Therapeutics Co's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Lumosa Therapeutics Co (ROCO:6535), the current Cyclically Adjusted Book per Share is NT$10.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lumosa Therapeutics Co (ROCO:6535) Overvalued in 2026?

Based on GuruFocus' analysis, Lumosa Therapeutics Co stock appears to be undervalued. The current stock price of NT$100.50 is trading 23.4% below its estimated GF Value™ of NT$131.16. GuruFocus considers Lumosa Therapeutics Co to be Modestly Undervalued.

Key valuation signals for ROCO:6535:

  • Cyclically Adjusted Book per Share: NT$10.86
  • GF Value™: NT$131.16 vs. price of NT$100.50 (23.4% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6535 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lumosa Therapeutics Co Business Description

Address Park Street, 4th Floor, No. 3-2, Nangang District, Taipei, TWN, 11503
Lumosa Therapeutics Co Ltd develops new drugs. The company is engaged in the development of drugs for unmet medical needs in the fields of oncology and Neuroscience. Geographically, it derives a majority of its revenue from Taiwan and also has a presence in Asia, and America. The product pipeline of the company is Neuroscience, which includes LT 1001 for Postoperative Pain, LT 3001 for Acute Ischemic Stroke, LT 5001 for Uremic Pruritus, LT 6001 for Neurological disorder, and Oncology, including LT 2003 for Solid Tumor. It generates revenue from sales of goods.
70GF Score

Get the complete analysis for ROCO:6535

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$100.50
Price
NT$131.16
GF Value